Evaluación del hemograma en caninos sanos sometidos a la administracion de cisplatina

Autores:: Calpa, Carlos
Daleck, Carlos
Teotônio de Castro, João

Tipo de recurso:: Article of journal

Fecha de publicación:: 2010

Institución:: Universidad de Córdoba

Repositorio:: Repositorio Institucional Unicórdoba

Idioma:: spa

id	UCORDOBA2_1b02d74c43a38c2a50f99fcf70c08967
oai_identifier_str	oai:repositorio.unicordoba.edu.co:ucordoba/5542
network_acronym_str	UCORDOBA2
network_name_str	Repositorio Institucional Unicórdoba
repository_id_str
dc.title.spa.fl_str_mv	Evaluación del hemograma en caninos sanos sometidos a la administracion de cisplatina
dc.title.translated.eng.fl_str_mv	Evaluación del hemograma en caninos sanos sometidos a la administracion de cisplatina
title	Evaluación del hemograma en caninos sanos sometidos a la administracion de cisplatina
spellingShingle	Evaluación del hemograma en caninos sanos sometidos a la administracion de cisplatina Cisplatin chemotherapy hemogram test haemoglobin white blood cells dogs
title_short	Evaluación del hemograma en caninos sanos sometidos a la administracion de cisplatina
title_full	Evaluación del hemograma en caninos sanos sometidos a la administracion de cisplatina
title_fullStr	Evaluación del hemograma en caninos sanos sometidos a la administracion de cisplatina
title_full_unstemmed	Evaluación del hemograma en caninos sanos sometidos a la administracion de cisplatina
title_sort	Evaluación del hemograma en caninos sanos sometidos a la administracion de cisplatina
dc.creator.fl_str_mv	Calpa, Carlos Daleck, Carlos Teotônio de Castro, João
dc.contributor.author.spa.fl_str_mv	Calpa, Carlos Daleck, Carlos Teotônio de Castro, João
dc.subject.spa.fl_str_mv	Cisplatin chemotherapy hemogram test haemoglobin white blood cells dogs
topic	Cisplatin chemotherapy hemogram test haemoglobin white blood cells dogs
publishDate	2010
dc.date.accessioned.none.fl_str_mv	2010-05-01 00:00:00 2022-07-01T20:59:03Z
dc.date.available.none.fl_str_mv	2010-05-01 00:00:00 2022-07-01T20:59:03Z
dc.date.issued.none.fl_str_mv	2010-05-01
dc.type.spa.fl_str_mv	Artículo de revista
dc.type.eng.fl_str_mv	Journal article
dc.type.coar.fl_str_mv	http://purl.org/coar/resource_type/c_2df8fbb1
dc.type.driver.spa.fl_str_mv	info:eu-repo/semantics/article
dc.type.coar.spa.fl_str_mv	http://purl.org/coar/resource_type/c_6501 http://purl.org/coar/resource_type/c_6501
dc.type.version.spa.fl_str_mv	info:eu-repo/semantics/publishedVersion
dc.type.content.spa.fl_str_mv	Text
dc.type.redcol.spa.fl_str_mv	http://purl.org/redcol/resource_type/ARTREF
dc.type.coarversion.spa.fl_str_mv	http://purl.org/coar/version/c_970fb48d4fbd8a85
format	http://purl.org/coar/resource_type/c_6501
status_str	publishedVersion
dc.identifier.issn.none.fl_str_mv	0122-0268
dc.identifier.uri.none.fl_str_mv	https://repositorio.unicordoba.edu.co/handle/ucordoba/5542
dc.identifier.doi.none.fl_str_mv	10.21897/rmvz.321
dc.identifier.url.none.fl_str_mv	https://doi.org/10.21897/rmvz.321
dc.identifier.eissn.none.fl_str_mv	1909-0544
identifier_str_mv	0122-0268 10.21897/rmvz.321 1909-0544
url	https://repositorio.unicordoba.edu.co/handle/ucordoba/5542 https://doi.org/10.21897/rmvz.321
dc.language.iso.spa.fl_str_mv	spa
language	spa
dc.relation.references.spa.fl_str_mv	Antunes LM, Bianchi ML. Antioxidantes da dieta como inibidores da nefrotoxicidade induzida pelo antitumoral cisplatina. Rev NutriCampinas 2004; 17(1):89–96. McKnight JA. Principles of chemotherapy. Clin Tech in Small Animal Practice 2003; 18(2):67–72. http://dx.doi.org/10.1053/svms.2003.36617 Wallace BM. Câncer drug pharmacology and clinical experience. In: Cancer in dogs and cats. China: Teton NewMedia, 2002. Kochevar DT, Mealey KM. Principles of cancer chemotherapy. Vet Med 1997; 92(4):339-349. Barger AM, Grindem CB. Hematologic abnormalities associated with cancer therapy. In: Feldman BF, Zinkl JG, Jain NC. Schalm's Veterinary Hematology. 5 ed. Canada: Lippincott Williams å Wilkins, 2000. Schaeppi U, Heyman IA, Fleischman RW, Rosenkrantz H, Ilievski V, Phelan R, Cooney DA, Ruth D. Davis RD. Cisplatina – dichlorodiammineplatinum (II) (NSC 119875): preclinical toxicologic evaluation of intravenous injection in dogs, monkeys and mice. Tox Appl Pharm 1973; 25:225-230. http://dx.doi.org/10.1016/S0041-008X(73)80009-2 O'Keefe DA, Harris CL. Toxicology of oncologic drugs. Vet Clin North Am Small Anim Pract 1990; 20(2):483-504. http://dx.doi.org/10.1016/S0195-5616(90)50040-6 Ogilvie GK, Moore AS. Managing the veterinary cancer patient. New Jersey: Veterinary learning systems company, 1995. Berg L. Canine Osteosarcoma: Amputation and chemotherapy. Vet Clin North Am Small Anim Pract1996; 26(1):111–121. Bradelin HA, Mansour S, Al M. Agentes ameliorating or augmenting the nephrotoxicity of cisplatin. Food Chem Toxicol2006: 44:1173–1183. Dagli MLZ. Agentes Antineoplasicos. In: Spinosa H, Górniak SM, Bernardi M M. Farmacologia aplicada a medicina veterinária. Rio de Janeiro: Guanabara Koogan; 2002. Andrade SF. Terapêutica antineoplasica. En: Andrade SF. Manual de terapêutica veterinária. São Paulo: ROCA; 2002. Rodaski S, De Nardi AB. Classificação dos quimioterápicos. En: Rodaski S, De Nardi ABQuimioterapia antineoplasica em cães e gatos.Curitiba: Bio Editora; 2006. Lanore D, Delprat C. Principais drogas. En: Lanore D, Delprat C. Quimioterapia anticancerígena. São Paulo: ROCA; 2004. Ogilvie GK. Chemoterapy and the surgery patient: Principles and recent advances. Vet Clin North Am Small Anim Pract 1998; 13(1):22–32. http://dx.doi.org/10.1016/S1096-2867(98)80023-6 Lee RH, Song JM, Park MY, Kang SK, Kim YK, Jung JS. Cisplatin-induced apoptosis by translocation of endogenous Bax in mouse collecting duct cells. Biochem Pharmacol 2001: 62:1013–1023. Schalm, OM, Jain NC, Carroll EJ. Veterinary Hematology. 2ed. Philadelphia: WB Saunders, 1975. Bonassa EMA. Conceitos gerais em quimioterapia antineoplásica. En: Bonassa EMA. Enfermagem em quimioterapia. São Paulo: Editora Atheneu, 2000. Hoagland HC. Hematologic complications of cancer chemotherapy. En: Perry MC, Yarbro JW. Toxicity of chemotherapy. Orlando: Grune & Stratton, 1984. Giger U. Oncologic emergencies in small animals. Part I. chemotherapy-related and hematologic emergencies. Compendium 1984; 6:689. Hahn KA. Et al. Hematologic changes associated with weekly low-dose ciaplatin adminitration in dogs. Vet Clin Pathol 1997; 26(1):29–31. http://dx.doi.org/10.1111/j.1939-165X.1997.tb00701.x Jain NC. Essentials of veterinary hematology. Comparative hematology of common domestic animals. Philadelphia: Lea & Febiger; 1993. Thrall MA. Hematologia e bioquímica clínica veterinária. São Paulo: Roca; 2007. Beiguelman BA. Análise de variância. En: Beiguelman BA. Curso practico de Bioestatística. Ribeirão Preto: FUNPEC – Editora; 2002. Morrow GR, Hickok JT, Rosenthal SN. Progress in reducing nausea and emesis. Cancer 1995; 76(3):343–357. http://dx.doi.org/10.1002/1097-0142(19950801)76:3<343::AID-CNCR2820760302>3.0.CO;2-V Dernell WS, Rodney CS, Withrow SJ. Tumors of the Skeletal System. En: Withrow SJ, MacEwen EG. Small animal clinical oncology. Philadelphia: W.B. Saunders Company, 2001. Martins MR, Daleck CR, Carvalho MB, Calado EB, Ziliotto L, Da Silva FMM. Avaliação dos efeitos de dois protocolos para administração de cisplatina sobre a função renal de cães. Acta Cir Bras 2003; 18(4):314-319. http://dx.doi.org/10.1590/S0102-86502003000400010
dc.relation.bitstream.none.fl_str_mv	https://revistamvz.unicordoba.edu.co/article/download/321/389
dc.relation.citationedition.spa.fl_str_mv	Núm. 2 , Año 2010 : Revista MVZ Córdoba Volumen 15(2) Mayo-Agosto 2010
dc.relation.citationissue.spa.fl_str_mv	2
dc.relation.citationvolume.spa.fl_str_mv	15
dc.relation.ispartofjournal.spa.fl_str_mv	Revista MVZ Córdoba
dc.rights.uri.spa.fl_str_mv	https://creativecommons.org/licenses/by-nc-sa/4.0/
dc.rights.accessrights.spa.fl_str_mv	info:eu-repo/semantics/openAccess
dc.rights.coar.spa.fl_str_mv	http://purl.org/coar/access_right/c_abf2
rights_invalid_str_mv	https://creativecommons.org/licenses/by-nc-sa/4.0/ http://purl.org/coar/access_right/c_abf2
eu_rights_str_mv	openAccess
dc.format.mimetype.spa.fl_str_mv	application/pdf
dc.publisher.spa.fl_str_mv	Universidad de Córdoba
dc.source.spa.fl_str_mv	https://revistamvz.unicordoba.edu.co/article/view/321
institution	Universidad de Córdoba
bitstream.url.fl_str_mv	https://repositorio.unicordoba.edu.co/bitstreams/557a742a-d66d-4c91-b344-5f0c9a37de68/download
bitstream.checksum.fl_str_mv	6bce915c52a7ef6b60f933f0ef7632b2
bitstream.checksumAlgorithm.fl_str_mv	MD5
repository.name.fl_str_mv	Repositorio Universidad de Córdoba
repository.mail.fl_str_mv	bdigital@metabiblioteca.com
_version_	1839636113171415040
spelling	Calpa, Carlos963bbe8e-1b82-414c-8b9a-30a0445d9ff7-1Daleck, Carlos5d27e1a8-4d3e-4eb6-a258-cb49e850145d-1Teotônio de Castro, João79d90a00-6dcb-44e8-b9cc-e0395f0ed563-12010-05-01 00:00:002022-07-01T20:59:03Z2010-05-01 00:00:002022-07-01T20:59:03Z2010-05-010122-0268https://repositorio.unicordoba.edu.co/handle/ucordoba/554210.21897/rmvz.321https://doi.org/10.21897/rmvz.3211909-0544application/pdfspaUniversidad de Córdobahttps://creativecommons.org/licenses/by-nc-sa/4.0/info:eu-repo/semantics/openAccesshttp://purl.org/coar/access_right/c_abf2https://revistamvz.unicordoba.edu.co/article/view/321Cisplatinchemotherapyhemogram testhaemoglobinwhite blood cellsdogsEvaluación del hemograma en caninos sanos sometidos a la administracion de cisplatinaEvaluación del hemograma en caninos sanos sometidos a la administracion de cisplatinaArtículo de revistaJournal articleinfo:eu-repo/semantics/articlehttp://purl.org/coar/resource_type/c_6501http://purl.org/coar/resource_type/c_6501http://purl.org/coar/resource_type/c_2df8fbb1info:eu-repo/semantics/publishedVersionTexthttp://purl.org/redcol/resource_type/ARTREFhttp://purl.org/coar/version/c_970fb48d4fbd8a85Antunes LM, Bianchi ML. Antioxidantes da dieta como inibidores da nefrotoxicidade induzida pelo antitumoral cisplatina. Rev NutriCampinas 2004; 17(1):89–96.McKnight JA. Principles of chemotherapy. Clin Tech in Small Animal Practice 2003; 18(2):67–72. http://dx.doi.org/10.1053/svms.2003.36617Wallace BM. Câncer drug pharmacology and clinical experience. In: Cancer in dogs and cats. China: Teton NewMedia, 2002.Kochevar DT, Mealey KM. Principles of cancer chemotherapy. Vet Med 1997; 92(4):339-349.Barger AM, Grindem CB. Hematologic abnormalities associated with cancer therapy. In: Feldman BF, Zinkl JG, Jain NC. Schalm's Veterinary Hematology. 5 ed. Canada: Lippincott Williams å Wilkins, 2000.Schaeppi U, Heyman IA, Fleischman RW, Rosenkrantz H, Ilievski V, Phelan R, Cooney DA, Ruth D. Davis RD. Cisplatina – dichlorodiammineplatinum (II) (NSC 119875): preclinical toxicologic evaluation of intravenous injection in dogs, monkeys and mice. Tox Appl Pharm 1973; 25:225-230. http://dx.doi.org/10.1016/S0041-008X(73)80009-2O'Keefe DA, Harris CL. Toxicology of oncologic drugs. Vet Clin North Am Small Anim Pract 1990; 20(2):483-504. http://dx.doi.org/10.1016/S0195-5616(90)50040-6Ogilvie GK, Moore AS. Managing the veterinary cancer patient. New Jersey: Veterinary learning systems company, 1995.Berg L. Canine Osteosarcoma: Amputation and chemotherapy. Vet Clin North Am Small Anim Pract1996; 26(1):111–121.Bradelin HA, Mansour S, Al M. Agentes ameliorating or augmenting the nephrotoxicity of cisplatin. Food Chem Toxicol2006: 44:1173–1183.Dagli MLZ. Agentes Antineoplasicos. In: Spinosa H, Górniak SM, Bernardi M M. Farmacologia aplicada a medicina veterinária. Rio de Janeiro: Guanabara Koogan; 2002.Andrade SF. Terapêutica antineoplasica. En: Andrade SF. Manual de terapêutica veterinária. São Paulo: ROCA; 2002.Rodaski S, De Nardi AB. Classificação dos quimioterápicos. En: Rodaski S, De Nardi ABQuimioterapia antineoplasica em cães e gatos.Curitiba: Bio Editora; 2006.Lanore D, Delprat C. Principais drogas. En: Lanore D, Delprat C. Quimioterapia anticancerígena. São Paulo: ROCA; 2004.Ogilvie GK. Chemoterapy and the surgery patient: Principles and recent advances. Vet Clin North Am Small Anim Pract 1998; 13(1):22–32. http://dx.doi.org/10.1016/S1096-2867(98)80023-6Lee RH, Song JM, Park MY, Kang SK, Kim YK, Jung JS. Cisplatin-induced apoptosis by translocation of endogenous Bax in mouse collecting duct cells. Biochem Pharmacol 2001: 62:1013–1023.Schalm, OM, Jain NC, Carroll EJ. Veterinary Hematology. 2ed. Philadelphia: WB Saunders, 1975.Bonassa EMA. Conceitos gerais em quimioterapia antineoplásica. En: Bonassa EMA. Enfermagem em quimioterapia. São Paulo: Editora Atheneu, 2000.Hoagland HC. Hematologic complications of cancer chemotherapy. En: Perry MC, Yarbro JW. Toxicity of chemotherapy. Orlando: Grune & Stratton, 1984.Giger U. Oncologic emergencies in small animals. Part I. chemotherapy-related and hematologic emergencies. Compendium 1984; 6:689.Hahn KA. Et al. Hematologic changes associated with weekly low-dose ciaplatin adminitration in dogs. Vet Clin Pathol 1997; 26(1):29–31. http://dx.doi.org/10.1111/j.1939-165X.1997.tb00701.xJain NC. Essentials of veterinary hematology. Comparative hematology of common domestic animals. Philadelphia: Lea & Febiger; 1993.Thrall MA. Hematologia e bioquímica clínica veterinária. São Paulo: Roca; 2007.Beiguelman BA. Análise de variância. En: Beiguelman BA. Curso practico de Bioestatística. Ribeirão Preto: FUNPEC – Editora; 2002.Morrow GR, Hickok JT, Rosenthal SN. Progress in reducing nausea and emesis. Cancer 1995; 76(3):343–357. http://dx.doi.org/10.1002/1097-0142(19950801)76:3<343::AID-CNCR2820760302>3.0.CO;2-VDernell WS, Rodney CS, Withrow SJ. Tumors of the Skeletal System. En: Withrow SJ, MacEwen EG. Small animal clinical oncology. Philadelphia: W.B. Saunders Company, 2001.Martins MR, Daleck CR, Carvalho MB, Calado EB, Ziliotto L, Da Silva FMM. Avaliação dos efeitos de dois protocolos para administração de cisplatina sobre a função renal de cães. Acta Cir Bras 2003; 18(4):314-319. http://dx.doi.org/10.1590/S0102-86502003000400010https://revistamvz.unicordoba.edu.co/article/download/321/389Núm. 2 , Año 2010 : Revista MVZ Córdoba Volumen 15(2) Mayo-Agosto 2010215Revista MVZ CórdobaPublicationOREORE.xmltext/xml2593https://repositorio.unicordoba.edu.co/bitstreams/557a742a-d66d-4c91-b344-5f0c9a37de68/download6bce915c52a7ef6b60f933f0ef7632b2MD51ucordoba/5542oai:repositorio.unicordoba.edu.co:ucordoba/55422023-10-06 00:46:19.857https://creativecommons.org/licenses/by-nc-sa/4.0/metadata.onlyhttps://repositorio.unicordoba.edu.coRepositorio Universidad de Córdobabdigital@metabiblioteca.com

Evaluación del hemograma en caninos sanos sometidos a la administracion de cisplatina

Publicaciones similares